首页 > 市场调查报告书 > 医疗设备

导管循环系统

市场调查报告书

商品编码

1764964

欧洲外周栓塞线圈市场预测（2031年）-区域分析-按类型、材料和应用

Europe Peripheral Embolization Coils Market Forecast to 2031 - Regional Analysis - by Type, Material, and Application

出版日期: 2025年04月14日 | 出版商:

The Insight Partners | 英文 117 Pages | 订单完成后即时交付

价格

简介目录图表

2023 年欧洲外周栓塞线圈市场价值为 1.8947 亿美元，预计到 2031 年将达到 2.6844 亿美元；预计 2023 年至 2031 年的复合年增长率为 4.5%。

癌症发生率上升推动欧洲週边栓塞线圈市场

大肠直肠癌、摄护腺癌、肺癌和子宫颈癌是最常见的癌症类型。根据世界卫生组织 (WHO) 统计，2022 年全球新增癌症病例约 2,000 万例，癌症死亡病例约 970 万例。此外，约有 5,300 万名癌症患者确诊后五年存活率较低。近五分之一的人一生中会罹患癌症；每 9 名男性中就有 1 名，每 12 名女性中就有 1 名死于癌症。根据同一资料来源估计，到 2050 年，全球新增癌症病例将达到约 3,500 万例，比 2022 年报告的病例数增加 77%。线圈栓塞技术广泛应用于治疗肺癌、肝癌、神经内分泌肿瘤、肾癌和子宫颈癌患者，因为栓塞线圈可以阻断或阻止血液流向肿瘤或组织异常部位。可拆卸和可推动的栓塞线圈均可用于填充或关闭血管。可推式弹簧圈是一种机械栓塞剂，用于动脉和静脉，可用于多种用途，包括止血、闭塞动脉瘤和动静脉瘻管等血管病变，以及重新分配血流以保护非目标血管。使用弹簧圈进行栓塞有助于防止动脉瘤和肿瘤生长，从而降低其对重要器官的伤害。因此，癌症病例的不断增加带来了对週边栓塞弹簧圈的大量需求。

欧洲週边栓塞线圈市场概况

欧洲外周栓塞线圈市场进一步细分为德国、英国、法国、义大利、西班牙和欧洲其他地区。欧洲在全球外周栓塞线圈市场中占有重要地位，预计在预测期内将录得强劲的成长率。该地区市场的成长主要归因于大肠直肠癌和胃肠道出血病例的激增。根据 GLOBOCAN 2020，德国在 2020 年记录了约 57,528 例新的结直肠病例（包括 26,654 例女性和 30,874 例男性）；其中近八分之一的病例在临床评估中显示大肠（结肠）或直肠癌变。根据美国国立卫生研究院 (NIH) 发布的一篇文章，急性胃肠道出血 (AGIB) 是一种常见的外科问题，在英国每年约有 85,000 例发生，即每 6 分钟发生 1 例。下消化道出血 (LGIB) 的年发生率为每 10,000 人 87 例。此类患者的住院总死亡率为 3.4% 至 17.8%。目前，当内视镜手术无法进行或无效时，栓塞术被推荐为急性危及生命的 LGIB 治疗的初步步骤。可脱性弹簧圈（可配合或不配合三轴系统）以及液体栓塞剂已被证明比其他栓塞剂更有效。

静脉曲张（静脉膨胀、充盈过度）在女性中十分常见，尤其是在孕妇和 65 岁以上的女性中。根据 Statista 统计，2020 年西班牙有超过 50 万名 65-74 岁女性被诊断出患有静脉曲张。精索静脉曲张栓塞治疗是一种门诊治疗，恢復时间极短。在此过程中，会在皮肤上（通常在腹股沟）製造一个小切口。将金属线圈放入导管，然后引导至精索静脉曲张的静脉曲张处。这可以有效地闭合受损的静脉，并透过健康静脉的其他路径将血液流回循环系统。欧洲其他地区包括波兰、奥地利、瑞士、瑞典、挪威、爱尔兰、丹麦、比利时和荷兰等发展中国家。根据全球癌症观察站的资料，2020 年比利时共诊断出 9,585 例新发大肠直肠癌病例，其中女性 4,150 例，男性 5,435 例。此外，2020 年挪威诊断出近 4,976 例新发大肠直肠癌病例。在瑞士，2020 年诊断出约 4,569 例新发大肠直肠癌病例。大肠直肠癌的常见併发症之一是胃肠道出血 (GIB)，通常与原发性肿瘤糜烂和出血有关。微线圈栓塞是减少胃肠道出血的有效方法。可推式线圈是上、下消化道出血最常使用的栓塞剂。

欧洲週边栓塞线圈市场收入及预测（2031年）（百万美元）

欧洲週边栓塞线圈市场细分

欧洲外周栓塞线圈市场按类型、材料、应用和国家分类。

根据类型，欧洲外周栓塞线圈市场分为可分离线圈和可推动线圈。 2023年，可分离线圈占据了较大的市占率。

就材质而言，欧洲週边栓塞线圈市场主要分为铂金、铂金水凝胶以及铂钨合金。铂金在2023年占据了最大的市场份额。

根据应用，欧洲週边栓塞线圈市场细分为出血和创伤、畸形、肿瘤、内臟动脉瘤、II型内漏和静脉曲张。出血和创伤领域在2023年占据了最大的市场。

根据国家/地区，欧洲週边栓塞线圈市场细分为英国、德国、法国、义大利、西班牙和欧洲其他地区。 2023年，德国占据了欧洲週边栓塞线圈市场份额的主导地位。

Medtronic Plc、Penumbra, Inc.、Balt、Boston Scientific Corp、Cook Medical Holdings LLC、Wallaby Medical、Spartan Micro Inc. 和 Terumo Corp. 是欧洲外周栓塞线圈市场的一些领先公司。

Colorectal, prostate, lung, and cervical cancer are the most common types of cancer. According to the World Health Organization (WHO), ~20 million new cancer cases and 9.7 million cancer-related fatalities were reported in 2022. Moreover, approximately 53 million cancer patients exhibited a five-year survival rate after diagnosis. Nearly 1 in 5 people develop cancer in their lifetime; 1 in 9 men and 1 in 12 women die due to cancer. According to the same source, new cancer cases are estimated to reach the count of ~35 million by 2050, with a 77% increase from the number of cases reported in 2022. The coil embolization technique is widely used to treat patients suffering from lung cancer, liver cancer, neuroendocrine tumors, renal cancer, and cervical cancer, as the embolization coil blocks or stops the flow of blood to a tumor or tissue abnormality. Both detachable and pushable embolizing coils can be used to fill or close blood vessels. The pushable coils are mechanical embolic agents used in arteries and veins for various indications, including controlling bleeding, occluding vascular lesions such as aneurysms and arteriovenous fistulas, and redistributing blood flow to protect non-target vessels. Embolization with coils helps prevent the growth of aneurysms and tumors, thus mitigating their ability to harm essential organs. Thus, the rising prevalence of cancer cases creates a high demand for peripheral embolization coils.

Europe Peripheral Embolization Coils Market Overview

The Europe peripheral embolization coils market is further segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Europe occupies a significant position in the global peripheral embolization coils market and is expected to record a strong growth rate during the forecast period. The market growth in the region is mainly attributed to the burgeoning cases of colorectal cancer and gastrointestinal bleeding. According to GLOBOCAN 2020, Germany recorded ~57,528 new colorectal cases (including 26,654 women and 30,874 men) in 2020; nearly one in eight of these cases show cancerous growth in the large intestine (colon) or rectum in clinical evaluation. According to an article released by the National Institutes of Health (NIH), acute gastrointestinal bleeding (AGIB) is a prevalent surgical problem, accounting for ~85,000 occurrences per year in the UK, i.e., 1 case every 6 minutes. The lower gastrointestinal bleeding (LGIB) has an estimated annual incidence of 87 per 10,000 persons. The overall mortality rate for such patients varies from 3.4% to 17.8% for inpatients. Embolization is currently advocated as the initial step in the treatment of acute, life-threatening LGIB when an endoscopic approach proves to be impossible or ineffective. Detachable coils (with or without a triaxial system), as well as liquid embolic agents, have proven to be more effective than other embolic agents.

Varicose veins (bulging, overfilled veins) are highly common among women, particularly during pregnancy and in women over the age of 65. According to Statista, more than 500,000 women aged 65-74 in Spain were diagnosed with varicose veins in 2020. Varicocele embolization is an outpatient treatment that requires minimal recovery time. During the process, a small nick is made in the skin (typically in the groin). Metal coils are put into the catheter before being guided into the varicocele's varicose veins. This effectively closes up the damaged veins and redirects blood flow back to the circulatory system via a different route through healthy veins. Rest of Europe includes developing countries such as Poland, Austria, Switzerland, Sweden, Norway, Ireland, Denmark, Belgium, and the Netherlands. As per the Global Cancer Observatory data, a total of 9,585 new colorectal cancer cases were diagnosed in Belgium in 2020, including 4,150 cases in women and 5,435 in men. Further, nearly 4,976 new colorectal cancer cases in Norway were diagnosed in 2020. In Switzerland, approximately 4,569 new colorectal cancer cases were diagnosed in 2020. One of the common complications of colorectal cancer is GIB, which is typically related to primary tumor erosion and hemorrhage. Microcoil embolization is an effective method for decreasing GIB. Pushable coils are the most common embolic agent utilized in both upper and lower gastrointestinal hemorrhage.

Europe Peripheral Embolization Coils Market Revenue and Forecast to 2031 (US$ Million)

Europe Peripheral Embolization Coils Market Segmentation

The Europe peripheral embolization coils market is categorized into type, material, application, and country.

Based on type, the Europe peripheral embolization coils market is bifurcated into detachable coil and pushable coil. The detachable coil segment held a larger market share in 2023.

In terms of material, the Europe peripheral embolization coils market is categorized into platinum, platinum & hydrogel, and platinum tungsten alloy. The platinum segment held the largest market share in 2023.

By application, the Europe peripheral embolization coils market is segmented into bleedings & trauma, malformations, tumours, visceral aneurysm, endoleak type II, and varicose veins. The bleedings & trauma segment held the largest market share in 2023.

Based on country, the Europe peripheral embolization coils market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe peripheral embolization coils market share in 2023.

Medtronic Plc; Penumbra, Inc.; Balt; Boston Scientific Corp; Cook Medical Holdings LLC; Wallaby Medical; Spartan Micro Inc.; and Terumo Corp. are some of the leading companies operating in the Europe peripheral embolization coils market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:

4. Europe Peripheral Embolization Coils Market - Key Market Dynamics

4.1 Market Drivers
- 4.1.1 Rise in Prevalence of Aortic Aneurysm
- 4.1.2 Increase in Incidence of Cancer
4.2 Market Restraints
- 4.2.1 Complications Arising During or After Embolization
4.3 Market Opportunities
- 4.3.1 Expanding Range of Applications of Embolization Coils
4.4 Future Trends
- 4.4.1 Growing Importance of Packing Density
4.5 Impact of Drivers and Restraints:

5. Peripheral Embolization Coils Market - Europe Analysis

5.1 Europe Peripheral Embolization Coils Market Overview
5.2 Peripheral Embolization Coils Market Revenue (US$ Million), 2021-2031
5.3 Peripheral Embolization Coils Market Forecast Analysis
5.4 Peripheral Embolization Coils Market: Company Positioning

6. Europe Peripheral Embolization Coils Market Analysis - by Product Type

6.1 Overview
6.2 Detachable Coil
- 6.2.1 Overview
- 6.2.2 Detachable Coil: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
6.3 Pushable Coil
- 6.3.1 Overview
- 6.3.2 Pushable Coil: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)

7. Europe Peripheral Embolization Coils Market Analysis - by Material

7.1 Overview
7.2 Platinum
- 7.2.1 Overview
- 7.2.2 Platinum: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
7.3 Platinum & Hydrogel
- 7.3.1 Overview
- 7.3.2 Platinum & Hydrogel: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
7.4 Platinum Tungsten Alloy
- 7.4.1 Overview
- 7.4.2 Platinum Tungsten Alloy: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)

8. Europe Peripheral Embolization Coils Market Analysis - by Application

8.1 Overview
8.2 Bleedings & Trauma
- 8.2.1 Overview
- 8.2.2 Bleedings & Trauma: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Malformations
- 8.3.1 Overview
- 8.3.2 Malformations: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
8.4 Tumors
- 8.4.1 Overview
- 8.4.2 Tumors: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
8.5 Visceral Aneurysms
- 8.5.1 Overview
- 8.5.2 Visceral Aneurysms: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
8.6 Endoleak Type II
- 8.6.1 Overview
- 8.6.2 Endoleak Type II: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
8.7 Varicose Veins
- 8.7.1 Overview
- 8.7.2 Varicose Veins: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)

9. Europe Peripheral Embolization Coils Market - Country Analysis

9.1 Europe: Market Overview
- 9.1.1 Europe: Peripheral Embolization Coils Market Breakdown, by Key Country, 2023 and 2031 (%)
  - 9.1.1.1 Germany: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
    - 9.1.1.1.1 Germany: Peripheral Embolization Coils Market Breakdown, by Product Type
    - 9.1.1.1.2 Germany: Peripheral Embolization Coils Market Breakdown, by Material
    - 9.1.1.1.3 Germany: Peripheral Embolization Coils Market Breakdown, by Application
  - 9.1.1.2 United Kingdom: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
    - 9.1.1.2.1 United Kingdom: Peripheral Embolization Coils Market Breakdown, by Product Type
    - 9.1.1.2.2 United Kingdom: Peripheral Embolization Coils Market Breakdown, by Material
    - 9.1.1.2.3 United Kingdom: Peripheral Embolization Coils Market Breakdown, by Application
  - 9.1.1.3 France: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
    - 9.1.1.3.1 France: Peripheral Embolization Coils Market Breakdown, by Product Type
    - 9.1.1.3.2 France: Peripheral Embolization Coils Market Breakdown, by Material
    - 9.1.1.3.3 France: Peripheral Embolization Coils Market Breakdown, by Application
  - 9.1.1.4 Italy: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
    - 9.1.1.4.1 Italy: Peripheral Embolization Coils Market Breakdown, by Product Type
    - 9.1.1.4.2 Italy: Peripheral Embolization Coils Market Breakdown, by Material
    - 9.1.1.4.3 Italy: Peripheral Embolization Coils Market Breakdown, by Application
  - 9.1.1.5 Spain: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
    - 9.1.1.5.1 Spain: Peripheral Embolization Coils Market Breakdown, by Product Type
    - 9.1.1.5.2 Spain: Peripheral Embolization Coils Market Breakdown, by Material
    - 9.1.1.5.3 Spain: Peripheral Embolization Coils Market Breakdown, by Application
  - 9.1.1.6 Rest of Europe: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
    - 9.1.1.6.1 Rest of Europe: Peripheral Embolization Coils Market Breakdown, by Product Type
    - 9.1.1.6.2 Rest of Europe: Peripheral Embolization Coils Market Breakdown, by Material
    - 9.1.1.6.3 Rest of Europe: Peripheral Embolization Coils Market Breakdown, by Application

10. Peripheral Embolization Coils Market-Industry Landscape

10.1 Overview
10.2 Growth Strategies in the Peripheral Embolization Coils Market
10.3 Inorganic Growth Strategies
- 10.3.1 Overview
10.4 Organic Growth Strategies
- 10.4.1 Overview

11. Company Profiles

11.1 Medtronic Plc
- 11.1.1 Key Facts
- 11.1.2 Business Description
- 11.1.3 Products and Services
- 11.1.4 Financial Overview
- 11.1.5 SWOT Analysis
- 11.1.6 Key Developments
11.2 Penumbra, Inc.
- 11.2.1 Key Facts
- 11.2.2 Business Description
- 11.2.3 Products and Services
- 11.2.4 Financial Overview
- 11.2.5 SWOT Analysis
- 11.2.6 Key Developments
11.3 Balt
- 11.3.1 Key Facts
- 11.3.2 Business Description
- 11.3.3 Products and Services
- 11.3.4 Financial Overview
- 11.3.5 SWOT Analysis
- 11.3.6 Key Developments
11.4 Boston Scientific Corp
- 11.4.1 Key Facts
- 11.4.2 Business Description
- 11.4.3 Products and Services
- 11.4.4 Financial Overview
- 11.4.5 SWOT Analysis
- 11.4.6 Key Developments
11.5 Cook Medical Holdings LLC
- 11.5.1 Key Facts
- 11.5.2 Business Description
- 11.5.3 Products and Services
- 11.5.4 Financial Overview
- 11.5.5 SWOT Analysis
- 11.5.6 Key Developments
11.6 Wallaby Medical
- 11.6.1 Key Facts
- 11.6.2 Business Description
- 11.6.3 Products and Services
- 11.6.4 Financial Overview
- 11.6.5 SWOT Analysis
- 11.6.6 Key Developments
11.7 Spartan Micro Inc.
- 11.7.1 Key Facts
- 11.7.2 Business Description
- 11.7.3 Products and Services
- 11.7.4 Financial Overview
- 11.7.5 SWOT Analysis
- 11.7.6 Key Developments
11.8 Terumo Corp
- 11.8.1 Key Facts
- 11.8.2 Business Description
- 11.8.3 Products and Services
- 11.8.4 Financial Overview
- 11.8.5 SWOT Analysis
- 11.8.6 Key Developments

12. Appendix

12.1 About The Insight Partners
12.2 Glossary of Terms

简介目录图表

List Of Tables

Table 1. Europe Peripheral Embolization Coils Market Segmentation
Table 2. Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
Table 3. Germany: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type
Table 4. Germany: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Material
Table 5. Germany: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 6. United Kingdom: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type
Table 7. United Kingdom: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Material
Table 8. United Kingdom: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 9. France: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type
Table 10. France: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Material
Table 11. France: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 12. Italy: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type
Table 13. Italy: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Material
Table 14. Italy: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 15. Spain: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type
Table 16. Spain: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Material
Table 17. Spain: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 18. Rest of Europe: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type
Table 19. Rest of Europe: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Material
Table 20. Rest of Europe: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 21. Recent Inorganic Growth Strategies in the Peripheral Embolization Coils Market
Table 22. Recent Organic Growth Strategies in the Peripheral Embolization Coils Market
Table 23. Glossary of Terms, Peripheral Embolization Coils Market

List Of Figures

Figure 1. Europe Peripheral Embolization Coils Market Segmentation, by Country
Figure 2. Peripheral Embolization Coils Market - Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Peripheral Embolization Coils Market Revenue (US$ Million), 2021-2031
Figure 5. Company Positioning
Figure 6. Peripheral Embolization Coils Market Share (%) - by Product Type (2023 and 2031)
Figure 7. Detachable Coil: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
Figure 8. Pushable Coil: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
Figure 9. Peripheral Embolization Coils Market Share (%) - by Material (2023 and 2031)
Figure 10. Platinum: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
Figure 11. Platinum & Hydrogel: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
Figure 12. Platinum Tungsten Alloy: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
Figure 13. Peripheral Embolization Coils Market Share (%) - by Application (2023 and 2031)
Figure 14. Bleedings & Trauma: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
Figure 15. Malformations: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
Figure 16. Tumors: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
Figure 17. Visceral Aneurysms: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
Figure 18. Endoleak Type II: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
Figure 19. Varicose Veins: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
Figure 20. Europe: Peripheral Embolization Coils Market, by Key Country - Revenue (2023) (US$ Million)
Figure 21. Europe: Peripheral Embolization Coils Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 22. Germany: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
Figure 23. United Kingdom: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
Figure 24. France: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
Figure 25. Italy: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
Figure 26. Spain: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
Figure 27. Rest of Europe: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
Figure 28. Growth Strategies in the Peripheral Embolization Coils Market